Sanofi has made a $30 million investment in GluBio, a Chinese biotechnology company focused on developing novel targeted protein degradation (TPD) therapies
https://seekingalpha.com/news/4550440-sanofi-makes-30m-investment-chinese-biotech-glubio
Sanofi has made a $30 million investment in GluBio, a Chinese biotechnology company focused on developing novel targeted protein degradation (TPD) therapies
https://seekingalpha.com/news/4550440-sanofi-makes-30m-investment-chinese-biotech-glubio
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.